Acute Care

What we do

We develop, manufacture and distribute the highest quality, and most innovative systems and data management solutions for Acute Care Diagnostics, spanning Blood Gas, Whole Blood Hemostasis and Bleeding Management. Our solutions help hospitals, hospital networks and commercial laboratories ensure quality results and enhance efficiency.

How we power patient care

As a market leader in Acute Care Diagnostics, our portfolio of integrative solutions delivers fast, actionable, lab-quality results at the point-of-care. Crucial to ensuring optimal patient management, our innovative whole blood, cartridge-based systems are simple to use and quality-assured. Accurate, reliable results, received quickly, help inform key patient management decisions clinicians make every day.

Acute Care

Giovanni Russi, COO Hemostasis and Acute Care
Giovanni Russi, COO Hemostasis and Acute Care

Launch of new flagship product and growth across all product lines

For Acute Care, 2024 was a year of excellent business growth across product lines and geographies, coupled with the commercialization of key innovations. Of note, we commercially launched our new flagship product, the GEM Premier 7000 with iQM3, a breakthrough in blood gas testing, in the United States. This system offers hemolysis detection at the point of care, for the very first time. This significant innovation has the potential to enhance both efficiency and patient care in hospitals around the world, as it continues to be commercialized in hospitals around the world.  

Finally, in December, we opened a new building, expanding our innovation capabilities in Specialized Diagnostics, at our Hemostasis and Acute Care Diagnostics Technology Center in Bedford, MA. This adds 105,000 additional square feet and represents an investment of more than US $50 million. It also increases our capacity from 1,200 employees today, to 2,000 employees, allowing growth in our Innovation program for several years to come.

Giovanni Russi
Chief Operating Officer
Hemostasis and Acute Care Diagnostics
  • 0 million

    in sales in 2024

  • 0

    Acute Care systems in clinical use

  • 0 million

    Acute Care tests sold in 2024

  • 0

    employees at Hemostasis and Acute Care technology centers

2024 business highlights

Excellent business growth across all regions. Globally +7.9% vs 2023 and above budget

Consistent success across all Acute Care product lines, Blood Gas, Whole Blood Hemostasis and Patient Blood Management

Strong instrument placements across GEM Premier 7000/5000/3500, ROTEM sigma/delta, GEM Hemochron 100/Hemochron Signature Elite and VerifyNow testing systems

Significant growth of installed base for our digital solutions GEMweb Plus 500 Custom Connectivity and GEMweb Live viewer

Commercial launch of new GEM Premier 7000 blood gas testing system in USA. Significant clinical value of hemolysis detection acknowledged by early adopters

IVDR clearance of GEM Premier 7000, enabling initiation of Controlled Distribution in the EU

GEMweb Live Clinical Decision Support, classified as a non-medical device in the EU, enabling initiation of Controlled Distribution in 2025

Our products: Powering Patient Care

GEM® PREMIER™ 7000 with iQM®3

Blood gas testing system

The GEM Premier 7000 with iQM3 represents a breakthrough in blood gas testing, offering hemolysis detection for the first time at the point-of-care.

GEM Premier 7000 with iQM3 system is part of our integrated and comprehensive Acute Care product portfolio — helping clinicians and laboratorians achieve better patient outcomes, lower total cost of care, assure accreditation compliance and improve operational efficiency in hospital acute care settings. 

Learn more

GEM® Premier™ 5000

Blood gas testing system

GEM Premier 5000 blood gas testing system provides automated quality assurance with every whole blood sample. With next-generation Intelligent Quality Management (iQM2), featuring IntraSpect™ technology, potential errors are detected not only before and after, but also during sample analysis, along with real-time correction and documentation. Plus, it’s simple—just change the all-in-one GEM PAK cartridge once a month. So regardless of testing location or point-of-care operator, quality results and compliance are assured with every sample.

Learn more
ROTEM Sigma

ROTEM® sigma

Viscoelastic testing system

ROTEM sigma is an easy-to-use, cartridge-based Thromboelastometry System that delivers rapid results at the point of care (POC), providing guidance in bleeding management. Used to assess clinically significant bleeding situations in cardiac surgery and liver transplantation, ROTEM TEMograms provide clear, real-time information, helping clinicians to optimize hemostasis while minimizing blood loss and blood product exposure, key goals of patient blood management programs.

Learn more

GEM® Hemochron® 100

ACT testing system

GEM Hemochron 100 Whole Blood Hemostasis system delivers quality results for monitoring and guiding unfractionated heparin therapy during cardiovascular procedures, including cardiac ablation and extracorporeal life support. Leveraging Hemochron technology, the system helps improve workflow and quality of care. Simple cartridge-based technology reduces maintenance and facilities training, for greater efficiency.

Learn more
GEMweb® Plus 500

GEMweb® Plus 500

Custom Connectivity

GEMweb Plus 500 Custom Connectivity is a data management solution, designed to simplify operator supervision and quality management, all from a single interface, whether accessed in the central lab, at the point-of-care or remotely from any analyzer, PC or tablet device.

Learn more
GEMweb Live

GEMweb® Live

Remote Viewer

A real-time onscreen viewer, GEMweb Live consolidates results from four Werfen systems in the cardiovascular operating room (CVOR). These comprehensive test results, all on one screen, enable faster clinical decision-making to help improve patient care.

Learn more
Note: All sales growth numbers are at Constant Exchange Rate and Constant Perimeter.